Publicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (8)

2022

  1. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction

    European Journal of Cancer, Vol. 132, pp. 53-60

2018

  1. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology, Vol. 85, Núm. 1-2, pp. 35-40

2017

  1. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))

    Nature Genetics

2016

  1. Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies

    EBioMedicine, Vol. 10, pp. 137-149

2014

  1. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Nature Genetics, Vol. 46, Núm. 7, pp. 736-741

2005

  1. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group

    Annals of Oncology, Vol. 16, Núm. 6, pp. 972-980